MEDICAMEN BIOTECH
Back to Cashflow Statement
|
MEDICAMEN BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-8.16 Cr | ₹-6.74 Cr | ₹-6.29 Cr | ₹4.11 Cr | ₹13 Cr |
What is the latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-8.16 Cr |
| Mar2024 | ₹-6.74 Cr |
| Mar2023 | ₹-6.29 Cr |
| Mar2022 | ₹4.11 Cr |
| Mar2021 | ₹13 Cr |
How is Cash Flow from Operating Activities of MEDICAMEN BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-8.16 Cr | Negative | |
| Mar2024 | ₹-6.74 Cr | Negative | |
| Mar2023 | ₹-6.29 Cr | Negative | |
| Mar2022 | ₹4.11 Cr | -67.83 | |
| Mar2021 | ₹13 Cr | - | |
Compare Cash Flow from Operating Activities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹426.8 Cr | -4% | 16% | 6.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -4% |
16% |
6.8% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses